This report on a recall of extra-strength acetaminophen tablets due to incomplete drug label outlines how labeling and packaging errors have been an ongoing problem, and specifically mentions ISMP’s alert on cisatracurium.
For the full text, visit Fierce Pharma online.
More News
Revised Tool Can Help Healthcare Organizations Update Their Own “Do Not Use” Lists
Nonprofit patient safety organization releases annual list of 10 patient safety threats in conjunction with Patient Safety Awareness week, March 10 to 16
This article appeared on the MyChesCo website on February 26, 2024.